These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 16387818

  • 1. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K, Sasaki T, Hanatani A, Kim J, Hashimura K, Ishida Y, Ohkaru Y, Asayama K, Tanaka T, Ogai A, Nakatani T, Kitamura S, Kangawa K, Miyatake K, Kitakaze M.
    Heart; 2006 May; 92(5):615-8. PubMed ID: 16387818
    [Abstract] [Full Text] [Related]

  • 2. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T, Takeishi Y, Arimoto T, Takabatake N, Nozaki N, Hirono O, Watanabe T, Nitobe J, Harada M, Suzuki S, Koyama Y, Kitahara T, Sasaki T, Kubota I.
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [Abstract] [Full Text] [Related]

  • 3. Incremental prognostic values of serum tenascin-C levels with blood B-type natriuretic peptide testing at discharge in patients with dilated cardiomyopathy and decompensated heart failure.
    Fujimoto N, Onishi K, Sato A, Terasaki F, Tsukada B, Nozato T, Yamada T, Imanaka-Yoshida K, Yoshida T, Ito M, Hiroe M.
    J Card Fail; 2009 Dec; 15(10):898-905. PubMed ID: 19944367
    [Abstract] [Full Text] [Related]

  • 4. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency.
    Yamashita T, Seino Y, Ogawa A, Ogata K, Fukushima M, Tanaka K, Mizuno K.
    J Cardiol; 2010 May; 55(3):377-83. PubMed ID: 20350516
    [Abstract] [Full Text] [Related]

  • 5. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.
    McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.
    Am J Cardiol; 2009 Jan 01; 103(1):22-8. PubMed ID: 19101224
    [Abstract] [Full Text] [Related]

  • 7. Clinical and prognostic value of Duke's Activity Status Index along with plasma B-type natriuretic peptide levels in chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Parissis JT, Nikolaou M, Birmpa D, Farmakis D, Paraskevaidis I, Bistola V, Katsoulas T, Filippatos G, Kremastinos DT.
    Am J Cardiol; 2009 Jan 01; 103(1):73-5. PubMed ID: 19101233
    [Abstract] [Full Text] [Related]

  • 8. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, Sabatine MS.
    Circulation; 2006 Aug 08; 114(6):550-7. PubMed ID: 16880323
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictive value of heart-type fatty acid-binding protein for left ventricular remodelling and clinical outcome of hypertensive patients with mild-to-moderate aortic valve diseases.
    Iida M, Yamazaki M, Honjo H, Kodama I, Kamiya K.
    J Hum Hypertens; 2007 Jul 08; 21(7):551-7. PubMed ID: 17392813
    [Abstract] [Full Text] [Related]

  • 11. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality.
    Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J.
    Crit Care Med; 2006 Apr 08; 34(4):995-1000. PubMed ID: 16484891
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Circulating levels of myocardial proteins predict future deterioration of congestive heart failure.
    Sugiura T, Takase H, Toriyama T, Goto T, Ueda R, Dohi Y.
    J Card Fail; 2005 Sep 08; 11(7):504-9. PubMed ID: 16198245
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C, Fischer C, Sindermann J, Stypmann J, Breithardt G, Gradaus R.
    Am J Cardiol; 2008 Aug 15; 102(4):469-74. PubMed ID: 18678308
    [Abstract] [Full Text] [Related]

  • 15. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, Barth JH, Hall AS.
    J Am Coll Cardiol; 2010 Jun 08; 55(23):2590-8. PubMed ID: 20513600
    [Abstract] [Full Text] [Related]

  • 16. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism.
    Kaczyñska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P.
    Clin Chim Acta; 2006 Sep 08; 371(1-2):117-23. PubMed ID: 16698008
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Serum matrix metalloproteinase-3 as a novel marker for risk stratification of patients with nonischemic dilated cardiomyopathy.
    Ohtsuka T, Nishimura K, Kurata A, Ogimoto A, Okayama H, Higaki J.
    J Card Fail; 2007 Nov 08; 13(9):752-8. PubMed ID: 17996824
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.